Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Anne Peters, MD

Professor of Clinical Medicine
Clinical Scholar
Keck School of Medicine of USC
Los Angeles, California

Disclosures

Anne Peters, MD, has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes Care (former); Vertex Pharmaceuticals Incorporated; Zealand (former)
Research funding from: Abbott Diabetes Care; Insulet Corporation
Stock options from: Omada Health; Teladoc

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES

Endocrine Physician Assistant
WVU Medicine Wheeling Hospital
Wellsburg, West Virginia

Disclosures

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES, has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes Care
Speaker or member of speakers bureau for: Abbott; Bayer; Novo Nordisk

Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES

Program Coordinator
Teen and Adolescent Diabetes Transition Program
University of Chicago's Kovler Diabetes Center
Chicago, Illinois

Disclosures

Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES, has the following relevant financial relationships:
Speaker or member of speakers bureau for: Abbott Diabetes Care; Xeris Pharmaceuticals

Eden M. Miller, DO

CEO
Diabetes and Obesity Care
Bend, Oregon

Disclosures

Eden M. Miller, DO, has no relevant financial relationships.

Editors

Anne G. Le, PharmD

Senior Medical Education Director, Medscape, LLC

Disclosures

Anne G. Le, PharmD, has no relevant financial relationships.

Frederick Stange, DO

Scientific Content Manager, Medscape, LLC

Disclosures

Frederick Stange, DO, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME / ABIM MOC

Tips and Tricks on Using Continuous Glucose Monitoring Data: The Experts Weigh In

Authors: Anne Peters, MD; Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES; Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES; Eden M. Miller, DO
CME / ABIM MOC Released: 3/22/2023
Valid for credit through: 3/22/2024

Start Activity

Credits Available

Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

ABIM Diplomates - maximum of 0.50 ABIM MOC points

You Are Eligible For
- Letter of Completion
- ABIM MOC points

Target Audience and Goal Statement

This activity is intended for primary care physicians, diabetologists and endocrinologists, and other healthcare professionals involved in the management of T2D.

The goal of this activity is for learners to successfully initiate CGM and use CGM data to inform T2D treatment decisions.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Data supporting use of CGM in patients with T2D
- Role of CGM in management of T2D

Disclosures

Faculty

Anne Peters, MD

Professor of Clinical Medicine
Clinical Scholar
Keck School of Medicine of USC
Los Angeles, California

Disclosures

Anne Peters, MD, has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes Care (former); Vertex Pharmaceuticals Incorporated; Zealand (former)
Research funding from: Abbott Diabetes Care; Insulet Corporation
Stock options from: Omada Health; Teladoc

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES

Endocrine Physician Assistant
WVU Medicine Wheeling Hospital
Wellsburg, West Virginia

Disclosures

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES, has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes Care
Speaker or member of speakers bureau for: Abbott; Bayer; Novo Nordisk

Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES

Program Coordinator
Teen and Adolescent Diabetes Transition Program
University of Chicago's Kovler Diabetes Center
Chicago, Illinois

Disclosures

Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES, has the following relevant financial relationships:
Speaker or member of speakers bureau for: Abbott Diabetes Care; Xeris Pharmaceuticals

Eden M. Miller, DO

CEO
Diabetes and Obesity Care
Bend, Oregon

Disclosures

Eden M. Miller, DO, has no relevant financial relationships.

Editors

Anne G. Le, PharmD

Senior Medical Education Director, Medscape, LLC

Disclosures

Anne G. Le, PharmD, has no relevant financial relationships.

Frederick Stange, DO

Scientific Content Manager, Medscape, LLC

Disclosures

Frederick Stange, DO, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CGM from A to Z

From Medscape Education Diabetes & Endocrinology

CME / ABIM MOC

Tips and Tricks on Using Continuous Glucose Monitoring Data: The Experts Weigh In

Authors: Anne Peters, MD; Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES; Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES; Eden M. Miller, DOFaculty and Disclosures

CME / ABIM MOC Released: 3/22/2023

Valid for credit through: 3/22/2024

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Data Supporting the Use of CGM in Type 2 Diabetes

Randomized clinical trial data demonstrate the value of CGM to improve clinical outcomes.
Anne Peters, MD

Continuous Glucose Monitoring: Ease of Use

Learn the differences between currently available CGM devices and how to educate your patients about them.
Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES

Continuous Glucose Monitoring: Reimbursement

Did you know you can get reimbursed for your time in training patients and interpreting CGM data?
Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES

Telemedicine and CGM

Gather practical tips to implement CGM in telemedicine in this commentary.
Eden M. Miller, DO

Learning Feedback Questions

Please answer these questions to complement your learning experience.

Page 1 of 7

CME / ABIM MOC Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Anne Peters, MD

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES

Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES

Eden M. Miller, DO

Editors

Anne G. Le, PharmD

Frederick Stange, DO

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Peer Reviewer

CME / ABIM MOC

Tips and Tricks on Using Continuous Glucose Monitoring Data: The Experts Weigh In

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Anne Peters, MD

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES

Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES

Eden M. Miller, DO

Editors

Anne G. Le, PharmD

Frederick Stange, DO

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Tips and Tricks on Using Continuous Glucose Monitoring Data: The Experts Weigh In

Contents of This CME Activity

Data Supporting the Use of CGM in Type 2 Diabetes

Continuous Glucose Monitoring: Ease of Use

Continuous Glucose Monitoring: Reimbursement

Telemedicine and CGM

Learning Feedback Questions